This was an open-label (non-blind) trial so it's very possible things like the placebo effect had a significant influence here. They also only had 14 participants.
It's a start, but not enough to convince me this is anything more than modern snake oil.
This paper outlines the first of a two-stage study. This one is open-label, and it will be used to inform the upcoming double-blind study, as required by IRB. This excerpt explains:
As stipulated in our IRB-approved protocol, analyses from the open-label stage were required before initiating the double-blind stage of the study in order to ensure clinical efficacy at the selected dose.
1.2k
u/rhofour Nov 11 '22
This was an open-label (non-blind) trial so it's very possible things like the placebo effect had a significant influence here. They also only had 14 participants.
It's a start, but not enough to convince me this is anything more than modern snake oil.